Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
41.01
+0.83 (2.07%)
May 22, 2026, 4:00 PM EDT - Market closed
Nanobiotix Revenue
In the year 2025, Nanobiotix had annual revenue of 32.59M EUR. Nanobiotix had revenue of 5.96M in the half year ending December 31, 2025, a decrease of -81.91%.
Revenue (ttm)
32.59M EUR
Revenue Growth
n/a
P/S Ratio
53.59
Revenue / Employee
325,930 EUR
Employees
100
Market Cap
2.05B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 32.59M | 39.78M | - |
| Dec 31, 2024 | -7.19M | -43.40M | - |
| Dec 31, 2023 | 36.21M | 31.43M | 658.12% |
| Dec 31, 2022 | 4.78M | 2.13M | 80.43% |
| Dec 31, 2021 | 2.65M | 135.00K | 5.37% |
| Dec 31, 2020 | 2.51M | -29.00K | -1.14% |
| Dec 31, 2019 | 2.54M | -938.00K | -26.96% |
| Dec 31, 2018 | 3.48M | -242.53K | -6.52% |
| Dec 31, 2017 | 3.72M | -1.70M | -31.36% |
| Dec 31, 2016 | 5.42M | 1.41M | 35.03% |
| Dec 31, 2015 | 4.02M | 1.24M | 44.91% |
| Dec 31, 2014 | 2.77M | 2.59M | 1,398.23% |
| Dec 31, 2013 | 184.94K | -785.67K | -80.95% |
| Dec 31, 2012 | 970.61K | -389.70K | -28.65% |
| Dec 31, 2011 | 1.36M | 225.46K | 19.87% |
| Dec 31, 2010 | 1.13M | -1.63M | -59.00% |
| Dec 31, 2009 | 2.77M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ADMA Biologics | 509.86M |
| Zai Lab | 453.28M |
| Aurinia Pharmaceuticals | 298.30M |
| Ascentage Pharma Group International | 82.08M |
| Zymeworks | 81.26M |
| Viridian Therapeutics | 70.92M |
| Mesoblast | 65.38M |
| Nektar Therapeutics | 55.63M |
NBTX News
- 9 hours ago - NANOBIOTIX Announces Full Exercise of Underwriters' Over-Allotment Option, Bringing Gross Proceeds of Offering to Approximately $100 Million - GlobeNewsWire
- 1 day ago - Nanobiotix (NBTX) Sees a Significant Decline in Share Price - GuruFocus
- 1 day ago - Nanobiotix falls -9.0% - TheFly
- 1 day ago - Nanobiotix Announces Pricing Of Global Offering Worth $98 Mln - Nasdaq
- 1 day ago - Nanobiotix Announces Pricing of Oversubscribed €85m Global Offering - GlobeNewsWire
- 1 day ago - Nanobiotix Resumes Trading Of Ordinary Shares On Euronext Paris - Nasdaq
- 1 day ago - Nanobiotix Announces Trading Resumption of Its Ordinary Shares on Euronext Paris - GlobeNewsWire
- 1 day ago - Nanobiotix Temporarily Halts Paris Trading Amid Global Offering; Stock Slides - Nasdaq